Fact CheckerSign in

NCT03760211Completed

A Mobile Gaming App to Improve ART Adherence for Youth

A Multisite Randomized Trial of Battle Viro: A Mobile Gaming App to Improve ART Adherence for Youth

Source: ClinicalTrials.gov · Last updated 6 Apr 2025

Brief summary (registry, in English)

Despite the need for consistent adherence to medical care, youth living with HIV have low rates of adherence to medications and treatment. There are few interventions to improve adherence to HIV medications and treatment for youth, and there is a great need for novel approaches that are engaging for this age group. The investigators developed an intervention that includes a mobile gaming app that is integrated with a 7-day electronic medication device and text messages. During gameplay, youth fight HIV in colorful organ systems. A small previous project found that the intervention helped youth who were newly starting medications for HIV by improving adherence and decreasing HIV virus in their bodies (viral load). This proposed project will test the intervention with larger number of youth (100) who are newly starting HIV treatment and medications in New England, Georgia, and in Mississippi. The investigators want to determine if adherence is improved and viral load is reduced in this larger sample.

Status (registry)
Completed
Study type
Interventional
Enrollment
107 (actual)
First submitted
19 Nov 2018
Start date
1 Nov 2019
Primary completion date
17 Oct 2024
Lead sponsor
Rhode Island Hospital
Diseases
HIV
NCT number
NCT03760211

What you commit to

  • Study type: Interventional
  • Participants enrolled: 107
  • From 1 Nov 2019 to the primary completion date, 17 Oct 2024
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Living with HIV
  • English speaking
  • Have started antiretroviral therapy (ART) in the last three months or restarted ART in the last three months after not taking ART for approximately six months
  • Have access to a smartphone for the duration of the study
  • Not involved with another HIV prevention or adherence related study
  • Able to give consent/assent and not impaired by cognitive or medical limitations as per clinical assessment
  • Detectable viral load

Age in the registry: 15 years to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emory University
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Boston Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
University of Mississippi Medical Center
Coordinator of this site? Confirm its status
JacksonUnited StatesUnknown status
Rhode Island Hospital
Coordinator of this site? Confirm its status
ProvidenceUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.